Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $28.7 million.

  • GeneDx Holdings' Shares Outstanding (Weighted Average) rose 6.65% to $28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 6.65%. This contributed to the annual value of $27.5 million for FY2024, which is 6.13% up from last year.
  • GeneDx Holdings' Shares Outstanding (Weighted Average) amounted to $28.7 million in Q3 2025, which was up 0.68% from $28.5 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Shares Outstanding (Weighted Average) registered a high of $28.7 million during Q3 2025, and its lowest value of $7.2 million during Q1 2021.
  • In the last 3 years, GeneDx Holdings' Shares Outstanding (Weighted Average) had a median value of $26.1 million in 2024 and averaged $26.7 million.
  • Data for GeneDx Holdings' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 451.45% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Shares Outstanding (Weighted Average) stood at $7.3 million in 2021, then spiked by 60.32% to $11.7 million in 2022, then surged by 120.84% to $25.9 million in 2023, then grew by 6.13% to $27.5 million in 2024, then rose by 6.65% to $28.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $28.7 million in Q3 2025, compared to $28.5 million in Q2 2025 and $28.1 million in Q1 2025.